- Record: found
- Abstract: not found
- Article: not found
CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer
Yichou Wei ,
Chao Lin ,
He Li ,
Zhiying Xu ,
Jieti Wang ,
Ruochen Li ,
Hao Liu ,
Heng Zhang ,
Hongyong He ,
Jiejie Xu
October 31 2017
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
<p class="first" id="d2495826e150">Chemokine (C-X-C motif) ligand 13 (CXCL13/BLC/BCA-1)
is a cytokine from C-X-C chemokine
family, which is selectively chemotactic for B cells. Previous research has demonstrated
that high CXCL13 expression is correlated to poor prognosis in various cancers. However,
the association between CXCL13 expression and gastric cancer is still unclear.
</p>